{"title":"Eosinophilic gastroenteritis with severe gastrointestinal intolerance: A case report and literature review.","authors":"Chen-Xiang Wei, Yi-De Gao, Rong Liang, Tao Lyu","doi":"10.1177/03000605251332886","DOIUrl":null,"url":null,"abstract":"<p><p>Eosinophilic gastroenteritis is a rare gastrointestinal disease characterized by eosinophilic infiltration of the gastrointestinal mucosa, muscle layer, or serosal layer. Gastrointestinal symptoms, laboratory tests, imaging, and endoscopy can provide important diagnostic basis for eosinophilic gastroenteritis, but the final diagnosis needs to be confirmed via pathological biopsy. We herein report the case of a middle-aged woman with abdominal pain for 5 days, which was aggravated for 1 day. Gastroscopic pathology showed individual nondiffuse eosinophils (concentration of <10 eosinophils/high power field) in the fundus and antrum. Eosinophils with a maximum concentration of 80/high power field were uniformly distributed in the stroma and specific epithelium of the duodenal bulb. Eosinophils were infiltrated in the submucosa as well as the perivascular and vascular walls of the descending duodenum, with a maximum concentration of approximately 130/high power field. After 5 days of intravenous meprednisolone treatment, the symptoms improved and the patient was discharged healthy. After reviewing the literature, we recommend that if a patient exhibits gastrointestinal symptoms and elevated blood eosinophil levels with co-existing atopic diseases, such as asthma and allergic rhinitis, the clinician should perform gastroenteroscopy and pathological biopsy after ruling out tumor, tuberculosis, and infection.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"53 4","pages":"3000605251332886"},"PeriodicalIF":1.4000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12046145/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of International Medical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03000605251332886","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Eosinophilic gastroenteritis is a rare gastrointestinal disease characterized by eosinophilic infiltration of the gastrointestinal mucosa, muscle layer, or serosal layer. Gastrointestinal symptoms, laboratory tests, imaging, and endoscopy can provide important diagnostic basis for eosinophilic gastroenteritis, but the final diagnosis needs to be confirmed via pathological biopsy. We herein report the case of a middle-aged woman with abdominal pain for 5 days, which was aggravated for 1 day. Gastroscopic pathology showed individual nondiffuse eosinophils (concentration of <10 eosinophils/high power field) in the fundus and antrum. Eosinophils with a maximum concentration of 80/high power field were uniformly distributed in the stroma and specific epithelium of the duodenal bulb. Eosinophils were infiltrated in the submucosa as well as the perivascular and vascular walls of the descending duodenum, with a maximum concentration of approximately 130/high power field. After 5 days of intravenous meprednisolone treatment, the symptoms improved and the patient was discharged healthy. After reviewing the literature, we recommend that if a patient exhibits gastrointestinal symptoms and elevated blood eosinophil levels with co-existing atopic diseases, such as asthma and allergic rhinitis, the clinician should perform gastroenteroscopy and pathological biopsy after ruling out tumor, tuberculosis, and infection.
期刊介绍:
_Journal of International Medical Research_ is a leading international journal for rapid publication of original medical, pre-clinical and clinical research, reviews, preliminary and pilot studies on a page charge basis.
As a service to authors, every article accepted by peer review will be given a full technical edit to make papers as accessible and readable to the international medical community as rapidly as possible.
Once the technical edit queries have been answered to the satisfaction of the journal, the paper will be published and made available freely to everyone under a creative commons licence.
Symposium proceedings, summaries of presentations or collections of medical, pre-clinical or clinical data on a specific topic are welcome for publication as supplements.
Print ISSN: 0300-0605